Rapid AMR Testing in the Fight Against Tuberculosis

Explore a groundbreaking innovation in health and biotechnology that significantly reduces antibiotic resistance testing time for tuberculosis in this 20-minute podcast episode. Delve into the radical advancement developed by EMPE Diagnostics, which received joint funding from the European Innovation Council (EIC) and the Bill & Melinda Gates Foundation. Listen as Iordanis Arzimanoglou, EIC programme manager for health and biotechnology and medical molecular geneticist, and Pavan Asalapuram, co-founder and Vice-CEO of EMPE Diagnostics, discuss the development, commercialization, and scaling up of this crucial technology. Gain insights into the challenges of treating tuberculosis, particularly in Eastern Europe, and learn how this innovation contributes to the fight against antimicrobial resistance. Discover the role of EUeic support and the collaborative efforts driving progress in rapid AMR testing for tuberculosis.

Intro
What is EUeic
Statistics on TB
TB in Eastern Europe
Challenges in treating TB
Discussion
EUeic support
Bill and Melinda Gates Foundation